Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

257.53
Delayed Data
As of Jul 31
 +3.25 / +1.28%
Today’s Change
106.00
Today|||52-Week Range
259.99
+79.95%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 290.00, with a high estimate of 310.00 and a low estimate of 229.00. The median estimate represents a +12.61% increase from the last price of 257.53.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.71
Sales
$2.8B
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.84%
 
 
 
 
 
 
Growthannually 38.88%
 
 
 
 
 
 

Sales

Growthquarterly 1.54%
 
 
 
 
 
 
Growthannually 32.73%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.